Johnson & Johnson Selling, General and Administrative Expense
Johnson & Johnson (JNJ) reported Selling, General and Administrative Expense of $6.43 billion for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-07-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-07-23
- Johnson & Johnson selling, general and administrative expense for the quarter ending 2026-06-28 was $6.43B, a 9.22% increase year-over-year.
- Johnson & Johnson selling, general and administrative expense for the quarter ending 2026-03-29 was $6.03B, a 18.04% increase year-over-year.
- Johnson & Johnson selling, general and administrative expense for the quarter ending 2025-12-28 was $6.75B, a 4.65% increase year-over-year.
- Johnson & Johnson selling, general and administrative expense for the quarter ending 2025-09-28 was $5.92B, a 8.11% increase year-over-year.
- Johnson & Johnson selling, general and administrative expense for fiscal 2025 was $23.68B, a 3.53% increase from fiscal 2024.
- Johnson & Johnson selling, general and administrative expense for fiscal 2024 was $22.87B, a 6.31% increase from fiscal 2023.
- Johnson & Johnson selling, general and administrative expense for fiscal 2023 was $21.51B, a 6.25% increase from fiscal 2023.
- Johnson & Johnson selling, general and administrative expense for fiscal 2023 was $20.25B, a 0.64% increase from fiscal 2022.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-28 | $6.43B 10-Q · filed 2026-07-23 | $12.47B 10-Q · filed 2026-07-23 | $19.22B derived: sum of 3 quarters · filed 2026-07-23 | $25.14B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2026-03-29 | $6.03B 10-Q · filed 2026-04-22 | $12.79B derived: sum of 2 quarters · filed 2026-04-22 | $18.71B derived: sum of 3 quarters · filed 2026-04-22 | $24.60B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-12-28 | $6.75B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $12.68B derived: sum of 2 quarters · filed 2026-02-11 | $18.56B derived: sum of 3 quarters · filed 2026-07-23 | $23.68B 10-K · filed 2026-02-11 | ||||
| 2025-09-28 | $5.92B 10-Q · filed 2025-10-22 | $11.81B derived: sum of 2 quarters · filed 2026-07-23 | $16.92B 10-Q · filed 2025-10-22 | $23.38B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-06-29 | $5.89B 10-Q · filed 2026-07-23 | $11.00B 10-Q · filed 2026-07-23 | $17.45B derived: sum of 3 quarters · filed 2026-07-23 | $22.93B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-03-30 | $5.11B 10-Q · filed 2026-04-22 | $11.56B derived: sum of 2 quarters · filed 2026-04-22 | $17.04B derived: sum of 3 quarters · filed 2026-04-22 | $22.72B derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2024-12-29 | $6.45B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $11.93B derived: sum of 2 quarters · filed 2026-02-11 | $17.61B derived: sum of 3 quarters · filed 2026-02-11 | $22.87B 10-K · filed 2026-02-11 | ||||
| 2024-09-29 | $5.48B 10-Q · filed 2025-10-22 | $11.16B derived: sum of 2 quarters · filed 2025-10-22 | $16.42B 10-Q · filed 2025-10-22 | $22.23B derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-06-30 | $5.68B 10-Q · filed 2025-07-24 | $10.94B 10-Q · filed 2025-07-24 | $16.75B derived: sum of 3 quarters · filed 2026-02-11 | $22.15B derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-03-31 | $5.26B 10-Q · filed 2025-04-23 | $11.07B derived: sum of 2 quarters · filed 2026-02-11 | $16.47B derived: sum of 3 quarters · filed 2026-02-11 | $21.86B derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2023-12-31 | $5.81B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $11.21B derived: sum of 2 quarters · filed 2026-02-11 | $16.61B derived: sum of 3 quarters · filed 2026-02-11 | $21.51B 10-K · filed 2026-02-11 | ||||
| 2023-10-01 | $5.40B 10-Q · filed 2024-10-23 | $10.80B derived: sum of 2 quarters · filed 2024-10-23 | $15.70B 10-Q · filed 2024-10-23 | $21.04B derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-07-02 | $5.40B 10-Q · filed 2024-07-25 | $6.67B 10-Q · filed 2023-07-31 | $10.30B 10-Q · filed 2024-07-25 | $12.80B 10-Q · filed 2023-07-31 | $15.64B derived: sum of 3 quarters · filed 2025-02-13 | $20.62B derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2023-04-02 | $4.91B 10-Q · filed 2024-05-01 | $6.14B 10-Q · filed 2023-04-28 | $10.24B derived: sum of 2 quarters · filed 2025-02-13 | $15.22B derived: sum of 3 quarters · filed 2025-02-13 | $21.45B derived: sum of 4 quarters · filed 2025-02-13 | |||
| 2023-01-01 | $5.34B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $10.31B derived: sum of 2 quarters · filed 2025-02-13 | $16.54B derived: sum of 3 quarters · filed 2025-02-13 | $20.25B 10-K · filed 2025-02-13 | $24.77B 10-K · filed 2023-02-16 | |||
| 2022-10-02 | $4.97B 10-Q · filed 2023-10-27 | $6.09B 10-Q · filed 2022-10-27 | $11.20B derived: sum of 2 quarters · filed 2023-10-27 | $14.91B 10-Q · filed 2023-10-27 | $18.25B 10-Q · filed 2022-10-27 | $19.75B derived: sum of 4 quarters · filed 2024-02-16 | ||
| 2022-07-03 | $6.23B 10-Q · filed 2023-07-31 | $12.16B 10-Q · filed 2023-07-31 | $14.78B derived: sum of 3 quarters · filed 2024-02-16 | $20.78B derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-04-03 | $5.94B 10-Q · filed 2023-04-28 | $8.55B derived: sum of 2 quarters · filed 2024-02-16 | $14.55B derived: sum of 3 quarters · filed 2024-02-16 | $20.62B derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-01-02 | $2.61B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $8.61B derived: sum of 2 quarters · filed 2024-02-16 | $14.69B derived: sum of 3 quarters · filed 2024-02-16 | $20.12B 10-K · filed 2024-02-16 | $24.66B 10-K · filed 2022-02-17 | |||
| 2021-10-03 | $6.00B 10-Q · filed 2022-10-27 | $12.07B derived: sum of 2 quarters · filed 2022-10-27 | $17.50B 10-Q · filed 2022-10-27 | $23.96B derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-07-04 | $6.07B 10-Q · filed 2022-07-29 | $11.51B 10-Q · filed 2022-07-29 | $17.96B derived: sum of 3 quarters · filed 2023-02-16 | $23.39B derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-04-04 | $5.43B 10-Q · filed 2022-04-29 | $11.89B derived: sum of 2 quarters · filed 2023-02-16 | $17.32B derived: sum of 3 quarters · filed 2023-02-16 | $22.31B derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-01-03 | $6.46B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $11.89B derived: sum of 2 quarters · filed 2023-02-16 | $16.88B derived: sum of 3 quarters · filed 2023-02-16 | $22.08B 10-K · filed 2023-02-16 | ||||
| 2020-09-27 | $5.43B 10-Q · filed 2021-10-29 | $10.42B derived: sum of 2 quarters · filed 2021-10-29 | $15.63B 10-Q · filed 2021-10-29 | $21.67B derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-06-28 | $4.99B 10-Q · filed 2021-07-29 | $10.20B 10-Q · filed 2021-07-29 | $16.23B derived: sum of 3 quarters · filed 2022-02-17 | $21.61B derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-03-29 | $5.20B 10-Q · filed 2021-04-30 | $11.24B derived: sum of 2 quarters · filed 2022-02-17 | $16.62B derived: sum of 3 quarters · filed 2022-02-17 | $22.16B derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2019-12-29 | $6.04B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $11.41B derived: sum of 2 quarters · filed 2022-02-17 | $16.96B derived: sum of 3 quarters · filed 2022-02-17 | $22.18B 10-K · filed 2022-02-17 | ||||
| 2019-09-29 | $5.37B 10-Q · filed 2020-10-23 | $10.92B derived: sum of 2 quarters · filed 2020-10-23 | $16.14B 10-Q · filed 2020-10-23 | $22.13B derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-06-30 | $5.55B 10-Q · filed 2020-07-24 | $10.77B 10-Q · filed 2020-07-24 | $16.76B derived: sum of 3 quarters · filed 2021-02-22 | $22.30B derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-03-31 | $5.22B 10-Q · filed 2020-04-29 | $11.21B derived: sum of 2 quarters · filed 2021-02-22 | $16.75B derived: sum of 3 quarters · filed 2021-02-22 | $22.50B derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2018-12-30 | $5.99B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $11.53B derived: sum of 2 quarters · filed 2021-02-22 | $17.28B derived: sum of 3 quarters · filed 2021-02-22 | $22.54B 10-K · filed 2021-02-22 | ||||
| 2018-09-30 | $5.54B 10-Q · filed 2019-10-28 | $11.29B derived: sum of 2 quarters · filed 2019-10-28 | $16.55B 10-Q · filed 2019-10-28 | $22.59B derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2018-07-01 | $5.74B 10-Q · filed 2019-07-29 | $11.01B 10-Q · filed 2019-07-29 | $17.05B derived: sum of 3 quarters · filed 2020-02-18 | $22.47B derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2018-04-01 | $5.26B 10-Q · filed 2019-05-01 | $11.31B derived: sum of 2 quarters · filed 2020-02-18 | $16.73B derived: sum of 3 quarters · filed 2020-02-18 | $22.02B derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2017-12-31 | $6.04B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $11.47B derived: sum of 2 quarters · filed 2020-02-18 | $16.76B derived: sum of 3 quarters · filed 2020-02-18 | $21.52B 10-K · filed 2020-02-18 | $21.42B 10-K · filed 2018-02-21 | |||
| 2017-10-01 | $5.42B 10-Q · filed 2018-10-31 | $5.40B 10-Q · filed 2017-11-02 | $10.71B derived: sum of 2 quarters · filed 2018-10-31 | $15.47B 10-Q · filed 2018-10-31 | $15.39B 10-Q · filed 2017-11-02 | $20.91B derived: sum of 4 quarters · filed 2019-02-20 | ||
| 2017-07-02 | $5.29B 10-Q · filed 2018-08-02 | $5.26B 10-Q · filed 2017-08-03 | $10.05B 10-Q · filed 2018-08-02 | $10.00B 10-Q · filed 2017-08-03 | $15.48B derived: sum of 3 quarters · filed 2019-02-20 | $20.25B derived: sum of 4 quarters · filed 2019-02-20 | ||
| 2017-04-02 | $4.76B 10-Q · filed 2018-05-01 | $4.74B 10-Q · filed 2017-05-08 | $10.19B derived: sum of 2 quarters · filed 2019-02-20 | $14.97B derived: sum of 3 quarters · filed 2019-02-20 | $20.14B derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2017-01-01 | $5.43B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $10.20B derived: sum of 2 quarters · filed 2019-02-20 | $15.38B derived: sum of 3 quarters · filed 2019-02-20 | $20.07B 10-K · filed 2019-02-20 | $19.95B 10-K · filed 2017-02-27 | |||
| 2016-10-02 | $4.77B 10-Q · filed 2017-11-02 | $9.95B derived: sum of 2 quarters · filed 2017-11-02 | $14.64B 10-Q · filed 2017-11-02 | $20.53B derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-07-03 | $5.18B 10-Q · filed 2017-08-03 | $9.86B 10-Q · filed 2017-08-03 | $15.76B derived: sum of 3 quarters · filed 2018-02-21 | $20.84B derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-04-03 | $4.69B 10-Q · filed 2017-05-08 | $10.58B derived: sum of 2 quarters · filed 2018-02-21 | $15.66B derived: sum of 3 quarters · filed 2018-02-21 | $21.04B derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-01-03 | $5.89B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $10.97B derived: sum of 2 quarters · filed 2018-02-21 | $16.36B derived: sum of 3 quarters · filed 2018-02-21 | $21.20B 10-K · filed 2018-02-21 | ||||
| 2015-09-27 | $5.08B 10-Q · filed 2016-11-04 | $10.46B derived: sum of 2 quarters · filed 2016-11-04 | $15.31B 10-Q · filed 2016-11-04 | $21.13B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-28 | $5.38B 10-Q · filed 2016-08-04 | $10.23B 10-Q · filed 2016-08-04 | $16.05B derived: sum of 3 quarters · filed 2017-02-27 | $21.52B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-29 | $4.85B 10-Q · filed 2016-05-10 | $10.67B derived: sum of 2 quarters · filed 2017-02-27 | $16.14B derived: sum of 3 quarters · filed 2017-02-27 | $21.62B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-28 | $5.82B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $11.29B derived: sum of 2 quarters · filed 2017-02-27 | $16.77B derived: sum of 3 quarters · filed 2017-02-27 | $21.95B 10-K · filed 2017-02-27 | ||||
| 2014-09-28 | $5.47B 10-Q · filed 2015-10-30 | $10.95B derived: sum of 2 quarters · filed 2015-10-30 | $16.13B 10-Q · filed 2015-10-30 | $22.05B derived: sum of 4 quarters · filed 2016-02-24 | ||||
| 2014-06-29 | $5.48B 10-Q · filed 2015-07-31 | $10.66B 10-Q · filed 2015-07-31 | $16.58B derived: sum of 3 quarters · filed 2016-02-24 | $21.89B derived: sum of 4 quarters · filed 2016-02-24 | ||||
| 2014-03-30 | $5.18B 10-Q · filed 2015-05-01 | $11.10B derived: sum of 2 quarters · filed 2016-02-24 | $16.41B derived: sum of 3 quarters · filed 2016-02-24 | $21.79B derived: sum of 4 quarters · filed 2016-02-24 | ||||
| 2013-12-29 | $5.92B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $11.23B derived: sum of 2 quarters · filed 2016-02-24 | $16.61B derived: sum of 3 quarters · filed 2016-02-24 | $21.83B 10-K · filed 2016-02-24 | ||||
| 2013-09-29 | $5.31B 10-Q · filed 2014-10-30 | $10.69B derived: sum of 2 quarters · filed 2014-10-30 | $15.91B 10-Q · filed 2014-10-30 | $21.57B derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $5.38B 10-Q · filed 2014-08-01 | $10.60B 10-Q · filed 2014-08-01 | $16.26B derived: sum of 3 quarters · filed 2015-02-24 | $21.49B derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | $5.22B 10-Q · filed 2014-05-02 | $10.88B derived: sum of 2 quarters · filed 2015-02-24 | $16.11B derived: sum of 3 quarters · filed 2015-02-24 | $21.08B derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-30 | $5.66B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $10.89B derived: sum of 2 quarters · filed 2015-02-24 | $15.85B derived: sum of 3 quarters · filed 2015-02-24 | $20.87B 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | $5.23B 10-Q · filed 2013-11-04 | $10.19B derived: sum of 2 quarters · filed 2013-11-04 | $15.21B 10-Q · filed 2013-11-04 | $20.67B derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-07-01 | $4.96B 10-Q · filed 2013-08-01 | $9.98B 10-Q · filed 2013-08-01 | $15.44B derived: sum of 3 quarters · filed 2014-02-21 | $20.68B derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-04-01 | $5.01B 10-Q · filed 2013-05-03 | $10.47B derived: sum of 2 quarters · filed 2014-02-21 | $15.71B derived: sum of 3 quarters · filed 2014-02-21 | $20.93B derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-01-01 | $5.46B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $10.70B derived: sum of 2 quarters · filed 2014-02-21 | $15.91B derived: sum of 3 quarters · filed 2014-02-21 | $20.97B 10-K · filed 2014-02-21 | ||||
| 2011-10-02 | $5.24B 10-Q · filed 2012-11-09 | $10.46B derived: sum of 2 quarters · filed 2012-11-09 | $15.51B 10-Q · filed 2012-11-09 | $20.69B derived: sum of 4 quarters · filed 2013-02-22 | ||||
| 2011-07-03 | $5.21B 10-Q · filed 2012-08-02 | $10.27B 10-Q · filed 2012-08-02 | $15.45B derived: sum of 3 quarters · filed 2013-02-22 | $20.16B derived: sum of 4 quarters · filed 2013-02-22 | ||||
| 2011-04-03 | $5.06B 10-Q · filed 2012-05-07 | $10.24B derived: sum of 2 quarters · filed 2013-02-22 | $14.95B derived: sum of 3 quarters · filed 2013-02-22 | $19.70B derived: sum of 4 quarters · filed 2013-02-22 | ||||
| 2011-01-02 | $5.18B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $9.89B derived: sum of 2 quarters · filed 2013-02-22 | $14.64B derived: sum of 3 quarters · filed 2013-02-22 | $19.42B 10-K · filed 2013-02-22 | ||||
| 2010-10-03 | $4.71B 10-Q · filed 2011-11-08 | $9.46B derived: sum of 2 quarters · filed 2011-11-08 | $14.24B 10-Q · filed 2011-11-08 | $19.87B derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-07-04 | $4.76B 10-Q · filed 2011-08-09 | $9.54B 10-Q · filed 2011-08-09 | $15.16B derived: sum of 3 quarters · filed 2012-02-23 | $19.93B derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-04-04 | $4.78B 10-Q · filed 2011-05-10 | $10.41B derived: sum of 2 quarters · filed 2012-02-23 | $15.18B derived: sum of 3 quarters · filed 2012-02-23 | $19.97B derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-01-03 | $5.63B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $10.40B derived: sum of 2 quarters · filed 2012-02-23 | $15.19B derived: sum of 3 quarters · filed 2012-02-23 | $19.80B 10-K · filed 2012-02-23 | ||||
| 2009-09-27 | $4.77B 10-Q · filed 2010-11-10 | $9.56B derived: sum of 2 quarters · filed 2010-11-10 | $14.17B 10-Q · filed 2010-11-10 | $19.84B derived: sum of 4 quarters · filed 2011-02-25 | ||||
| 2009-06-28 | $4.80B 10-Q · filed 2010-08-11 | $9.40B 10-Q · filed 2010-08-11 | $15.07B derived: sum of 3 quarters · filed 2011-02-25 | $20.27B derived: sum of 4 quarters · filed 2011-02-25 | ||||
| 2009-03-29 | $4.61B 10-Q · filed 2010-05-10 | $10.27B derived: sum of 2 quarters · filed 2011-02-25 | $15.47B derived: sum of 3 quarters · filed 2011-02-25 | $20.98B derived: sum of 4 quarters · filed 2011-02-25 | ||||
| 2008-12-28 | $5.67B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $10.86B derived: sum of 2 quarters · filed 2011-02-25 | $16.37B derived: sum of 3 quarters · filed 2011-02-25 | $21.49B 10-K · filed 2011-02-25 | ||||
| 2008-09-28 | $5.20B 10-Q · filed 2009-11-04 | $10.70B derived: sum of 2 quarters · filed 2009-11-04 | $15.82B 10-Q · filed 2009-11-04 | |||||
| 2008-06-29 | $5.51B 10-Q · filed 2009-08-04 | $10.63B 10-Q · filed 2009-08-04 | ||||||
| 2007-12-30 | $20.45B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |